aspartic acid has been researched along with isradipine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, T; Fujiwara, T; Itoyama, Y; Kato, H; Nagaki, S; Shuto, K | 1 |
| Babu, SH; Mohapatra, PK; Srivastava, R; Varshney, KK | 1 |
2 other study(ies) available for aspartic acid and isradipine
| Article | Year |
|---|---|
Effects of vinconate on age-related alterations in [3H]MK-801, [3H]glycine, sodium-dependent D-[3H]aspartate, [3H]FK-506 and [3H]PN200-110 binding in rats.
Topics: Aging; Animals; Aspartic Acid; Autoradiography; Brain; Calcium Channels; Carrier Proteins; Dizocilpine Maleate; DNA-Binding Proteins; Excitatory Amino Acid Antagonists; Glycine; Heat-Shock Proteins; Isradipine; Male; Rats; Rats, Inbred F344; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Sodium; Tacrolimus; Tacrolimus Binding Proteins; Tissue Distribution; Vinca Alkaloids | 1997 |
Formulation and Evaluation of Isradipine Nanosuspension and Exploring its Role as a Potential Anticancer Drug by Computational Approach.
Topics: Antineoplastic Agents; Aspartic Acid; Biological Availability; Humans; Isradipine; Metalloproteases; Nanoparticles; Particle Size; Peptide Hydrolases; Polymers; Solubility; Suspensions | 2022 |